Meta流行病学研究的报告规范解读  

Interpretation of guideline for reporting meta-epidemiological research

作　　者：郭嘉琪 龙囿霖 林春滢 王心怡 郭琼 林逸飞[4] 黄进[2,3] 杨克虎[5,6,7] 章仲恒 徐畅[9] 商洪才 杜亮[2,3] GUO Jiaqi;LONG Youlin;LIN Chunying;WANG Xinyi;GUO Qiong;LIN Yifei;HUANG Jin;YANG Kehu;ZHANG Zhongheng;XU Chang;SHANG Hongcai;DU Liang(West China School of Public Health,Sichuan University,Chengdu 610041,P.R.China;Medical Device Regulatory Research and Evaluation Center,West China Hospital,Sichuan University,Chengdu 610041,P.R.China;Chinese Evidence-based Medicine Center,West China Hospital,Sichuan University,Chengdu 610041,P.R.China;Medical Device Regulatory Research and Evaluation Centre,West China Hospital,Sichuan University,Chengdu 610041,P.R.China;Evidence-Based Medicine Center,School of Basic Medical Sciences,Lanzhou University,Lanzhou 730000,P.R.China;Key Laboratory of Evidence-Based Medicine and Knowledge Translation of Gansu Province,Lanzhou 730000,P.R.China;Evidence-Based Social Science Center,School of Public Health,Lanzhou University,Lanzhou 730000,P.R.China;Department of Emergency Medicine,Sir Run Shaw Hospital,Zhejiang University School of Medicine,Hangzhou 310016,P.R.China;Department of Population Medicine,College of Medicine,Qatar University,Doha 2731,Qatar;Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,P.R.China)

机构地区：[1]四川大学华西公共卫生学院,成都610041 [2]四川大学华西医院医疗器械监管研究与评价中心,成都610041 [3]四川大学华西医院中国循证医学中心,成都610041 [4]四川大学华西医院精准医学中心,成都610041 [5]兰州大学基础医学院循证医学中心,兰州73000 [6]甘肃省循证医学与临床转化重点实验室,兰州73000 [7]兰州大学公共卫生学院循证社会科学中心,兰州730000 [8]浙江大学医学院附属邵逸夫医院急诊医学科,杭州310016 [9]卡塔尔大学医学院人群医学系,卡塔尔多哈2731 [10]北京中医药大学东直门医院中医内科学教育部和北京市重点实验室,北京100700

出　　处：《中国循证医学杂志》2022年第9期1071-1079,共9页Chinese Journal of Evidence-based Medicine

基　　金：国家自然科学基金项目(编号:81873197、72074161);四川省科技厅项目(编号:2019YFS0194)。

摘　　要：Meta流行病学报告规范基于PRISMA制订,旨在增加Meta流行病学研究的报告质量和透明度。本文对Meta流行病学报告规范的24个条目进行介绍和解读,以期为研究人员规范报告Meta流行病学研究提供参考。The guideline for reporting meta-epidemiological research,based on PRISMA,aims to increase the reporting quality and transparency of meta-epidemiological studies.This paper introduced and interpreted the 24reporting items in the guidelines for reporting meta-epidemiological research to provide a reference for standardizing the reporting of meta-epidemiological studies.

关 键 词：Meta流行病学 报告规范 解读 

分 类 号：R181[医药卫生—流行病学]